{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T01:32:05Z","timestamp":1790040725990,"version":"4.0.1"},"reference-count":37,"publisher":"American Medical Association (AMA)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Cardiol"],"published-print":{"date-parts":[[2019,7,1]]},"DOI":"10.1001\/jamacardio.2019.1176","type":"journal-article","created":{"date-parts":[[2019,5,8]],"date-time":"2019-05-08T11:07:46Z","timestamp":1557313666000},"page":"702","source":"Crossref","is-referenced-by-count":74,"title":["Update on Clinical Trials of Losartan With and Without \u03b2-Blockers to Block Aneurysm Growth in Patients With Marfan Syndrome"],"prefix":"10.1001","volume":"4","author":[{"given":"Marion A.","family":"Hofmann Bowman","sequence":"first","affiliation":[{"name":"Frankel Cardiovascular Center, University of Michigan, Ann Arbor"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim A.","family":"Eagle","sequence":"additional","affiliation":[{"name":"Frankel Cardiovascular Center, University of Michigan, Ann Arbor"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dianna M.","family":"Milewicz","sequence":"additional","affiliation":[{"name":"McGovern Medical School, University of Texas Health Science Center at Houston"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"1","key":"hrv190005r1","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/0041-008X(70)90170-5","article-title":"Beta-aminopropionitrile-induced dissecting aneurysms of turkeys: treatment with propranolol.","volume":"16","author":"Simpson","year":"1970","journal-title":"Toxicol Appl Pharmacol"},{"issue":"4","key":"hrv190005r2","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1161\/01.CIR.65.4.704","article-title":"Effect of hydralazine on aortic rupture induced by B-aminopropionitrile in turkeys.","volume":"65","author":"Simpson","year":"1982","journal-title":"Circulation"},{"issue":"19","key":"hrv190005r3","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1056\/NEJM199405123301902","article-title":"Progression of aortic dilatation and the benefit of long-term beta-adrenergic blockade in Marfan\u2019s syndrome.","volume":"330","author":"Shores","year":"1994","journal-title":"N Engl J Med"},{"issue":"13","key":"hrv190005r4","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1161\/CIR.0b013e3181d47d48","article-title":"2010 ACCF\/AHA\/AATS\/ACR\/ASA\/SCA\/SCAI\/SIR\/STS\/SVM guidelines for the diagnosis and management of patients with thoracic aortic disease: executive summary. A report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines, American Association for Thoracic Surgery, American College of Radiology, American Stroke Association, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society of Thoracic Surgeons, and Society for Vascular Medicine.","volume":"121","author":"Hiratzka","year":"2010","journal-title":"Circulation"},{"issue":"19","key":"hrv190005r5","doi-asserted-by":"publisher","first-page":"e127","DOI":"10.1016\/j.jacc.2017.11.006","article-title":"2017 ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APhA\/ASH\/ASPC\/NMA\/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines.","volume":"71","author":"Whelton","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"5770","key":"hrv190005r6","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1126\/science.1124287","article-title":"Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome.","volume":"312","author":"Habashi","year":"2006","journal-title":"Science"},{"issue":"6","key":"hrv190005r7","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1161\/01.CIR.103.6.789","article-title":"Angiotensin II blockade reverses myocardial fibrosis in a transgenic mouse model of human hypertrophic cardiomyopathy.","volume":"103","author":"Lim","year":"2001","journal-title":"Circulation"},{"issue":"6027","key":"hrv190005r8","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1126\/science.1192152","article-title":"Angiotensin II type 2 receptor signaling attenuates aortic aneurysm in mice through ERK antagonism.","volume":"332","author":"Habashi","year":"2011","journal-title":"Science"},{"issue":"26","key":"hrv190005r9","doi-asserted-by":"publisher","first-page":"2787","DOI":"10.1056\/NEJMoa0706585","article-title":"Angiotensin II blockade and aortic-root dilation in Marfan\u2019s syndrome.","volume":"358","author":"Brooke","year":"2008","journal-title":"N Engl J Med"},{"issue":"22","key":"hrv190005r10","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.1056\/NEJMoa1404731","article-title":"Atenolol versus losartan in children and young adults with Marfan\u2019s syndrome.","volume":"371","author":"Lacro","year":"2014","journal-title":"N Engl J Med"},{"issue":"32","key":"hrv190005r11","doi-asserted-by":"publisher","first-page":"2160","DOI":"10.1093\/eurheartj\/ehv151","article-title":"Marfan Sartan: a randomized, double-blind, placebo-controlled trial.","volume":"36","author":"Milleron","year":"2015","journal-title":"Eur Heart J"},{"issue":"45","key":"hrv190005r12","doi-asserted-by":"publisher","first-page":"3491","DOI":"10.1093\/eurheartj\/eht334","article-title":"Losartan reduces aortic dilatation rate in adults with Marfan syndrome: a randomized controlled trial.","volume":"34","author":"Groenink","year":"2013","journal-title":"Eur Heart J"},{"issue":"2","key":"hrv190005r13","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1161\/CIRCGENETICS.114.000950","article-title":"Beneficial outcome of losartan therapy depends on type of FBN1 mutation in Marfan syndrome.","volume":"8","author":"Franken","year":"2015","journal-title":"Circ Cardiovasc Genet"},{"issue":"12","key":"hrv190005r15","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1093\/eurheartj\/ehv575","article-title":"Efficacy of losartan vs. atenolol for the prevention of aortic dilation in Marfan syndrome: a randomized clinical trial.","volume":"37","author":"Forteza","year":"2016","journal-title":"Eur Heart J"},{"issue":"3","key":"hrv190005r16","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.mayocp.2012.11.005","article-title":"Losartan added to \u00df-blockade therapy for aortic root dilation in Marfan syndrome: a randomized, open-label pilot study.","volume":"88","author":"Chiu","year":"2013","journal-title":"Mayo Clin Proc"},{"issue":"6","key":"hrv190005r17","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1080\/00015385.2017.1314134","article-title":"Efficacy of losartan as add-on therapy to prevent aortic growth and ventricular dysfunction in patients with Marfan syndrome: a randomized, double-blind clinical trial.","volume":"72","author":"Mui\u00f1o-Mosquera","year":"2017","journal-title":"Acta Cardiol"},{"issue":"6","key":"hrv190005r18","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.echo.2013.02.018","article-title":"Echocardiographic methods, quality review, and measurement accuracy in a randomized multicenter clinical trial of Marfan syndrome.","volume":"26","author":"Selamet Tierney","year":"2013","journal-title":"J Am Soc Echocardiogr"},{"issue":"14","key":"hrv190005r19","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1016\/j.jacc.2018.07.052","article-title":"Losartan versus atenolol for prevention of aortic dilation in patients with Marfan syndrome.","volume":"72","author":"Teixido-Tura","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"hrv190005r20","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1016\/j.ahj.2007.06.024","article-title":"Rationale and design of a randomized clinical trial of beta-blocker therapy (atenolol) versus angiotensin II receptor blocker therapy (losartan) in individuals with Marfan syndrome.","volume":"154","author":"Lacro","year":"2007","journal-title":"Am Heart J"},{"issue":"12","key":"hrv190005r21","doi-asserted-by":"publisher","first-page":"3637","DOI":"10.1172\/JCI38308","article-title":"An adventitial IL-6\/MCP1 amplification loop accelerates macrophage-mediated vascular inflammation leading to aortic dissection in mice.","volume":"119","author":"Tieu","year":"2009","journal-title":"J Clin Invest"},{"issue":"2","key":"hrv190005r22","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1001\/jamacardio.2016.4910","article-title":"Cardiomyopathy in muscular dystrophy: when to treat?","volume":"2","author":"McNally","year":"2017","journal-title":"JAMA Cardiol"},{"issue":"2","key":"hrv190005r23","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1001\/jamacardio.2016.4801","article-title":"Myocardial fibrosis progression in Duchenne and Becker muscular dystrophy: a randomized clinical trial.","volume":"2","author":"Silva","year":"2017","journal-title":"JAMA Cardiol"},{"key":"hrv190005r24","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1146\/annurev-med-100415-022956","article-title":"Therapeutics targeting drivers of thoracic aortic aneurysms and acute aortic dissections: insights from predisposing genes and mouse models.","volume":"68","author":"Milewicz","year":"2017","journal-title":"Annu Rev Med"},{"issue":"8","key":"hrv190005r25","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1038\/ng.2349","article-title":"Loss-of-function mutations in TGFB2 cause a syndromic presentation of thoracic aortic aneurysm.","volume":"44","author":"Lindsay","year":"2012","journal-title":"Nat Genet"},{"issue":"1","key":"hrv190005r26","doi-asserted-by":"publisher","first-page":"e004968","DOI":"10.1161\/JAHA.116.004968","article-title":"Aortopathy in a mouse model of Marfan syndrome is not mediated by altered transforming growth factor beta signaling.","volume":"6","author":"Wei","year":"2017","journal-title":"J Am Heart Assoc"},{"issue":"4","key":"hrv190005r27","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1161\/ATVBAHA.114.305150","article-title":"Dimorphic effects of transforming growth factor-\u00df signaling during aortic aneurysm progression in mice suggest a combinatorial therapy for Marfan syndrome.","volume":"35","author":"Cook","year":"2015","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"2","key":"hrv190005r28","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1172\/JCI38136","article-title":"TGF-beta activity protects against inflammatory aortic aneurysm progression and complications in angiotensin II-infused mice.","volume":"120","author":"Wang","year":"2010","journal-title":"J Clin Invest"},{"issue":"6","key":"hrv190005r29","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1161\/CIRCRESAHA.115.307130","article-title":"LOX mutations predispose to thoracic aortic aneurysms and dissections.","volume":"118","author":"Guo","year":"2016","journal-title":"Circ Res"},{"key":"hrv190005r30","doi-asserted-by":"crossref","DOI":"10.1038\/srep10568","article-title":"Origin and evolution of lysyl oxidases.","author":"Grau-Bove","year":"2015","journal-title":"Scientific Rep"},{"issue":"20","key":"hrv190005r31","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.1161\/CIRCULATIONAHA.112.000483","article-title":"Population-based study of incidence and outcome of acute aortic dissection and premorbid risk factor control: 10-year results from the Oxford Vascular Study.","volume":"127","author":"Howard","year":"2013","journal-title":"Circulation"},{"key":"hrv190005r32","first-page":"CD011103","article-title":"Beta-blockers for preventing aortic dissection in Marfan syndrome.","volume":"11","author":"Koo","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"hrv190005r33","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.ijcard.2005.11.116","article-title":"The effect of beta-blocker therapy on clinical outcome in patients with Marfan\u2019s syndrome: a meta-analysis.","volume":"114","author":"Gersony","year":"2007","journal-title":"Int J Cardiol"},{"issue":"11","key":"hrv190005r34","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1016\/j.jacc.2016.06.025","article-title":"Risk of aortic dissection in the moderately dilated ascending aorta.","volume":"68","author":"Kim","year":"2016","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"hrv190005r35","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/S0828-282X(10)70370-6","article-title":"The prevalence and clinical impact of obesity in adults with Marfan syndrome.","volume":"26","author":"Yetman","year":"2010","journal-title":"Can J Cardiol"},{"key":"hrv190005r36","doi-asserted-by":"publisher","first-page":"e08648","DOI":"10.7554\/eLife.08648","article-title":"A deleterious gene-by-environment interaction imposed by calcium channel blockers in Marfan syndrome.","volume":"4","author":"Doyle","year":"2015","journal-title":"Elife"},{"issue":"4","key":"hrv190005r37","doi-asserted-by":"publisher","first-page":"354","DOI":"10.2459\/JCM.0b013e3283232a45","article-title":"Rationale and design of a trial evaluation the effects of losartan vs nebiviol vs the association of both on the progression of aortic root dilation in Marfan syndrome with FBN1 gene mutations.","volume":"10","author":"Gamarin","year":"2009","journal-title":"J Cardiovasc Med (Hagerstown)"},{"key":"hrv190005r14","unstructured":"European Society of Cardiology. Blood pressure drug slows aortic dilatation in Marfan syndrome. https:\/\/www.escardio.org\/The-ESC\/Press-Office\/Press-releases\/blood-pressure-drug-slows-aortic-dilatation-in-marfan-syndrome Published online August 28, 2018. Accessed April 1, 2019."}],"container-title":["JAMA Cardiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/\/jamacardiology\/article-pdf\/4\/7\/702\/17729306\/jamacardiology_hofmann_bowman_2019_rv_190005.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,17]],"date-time":"2019-07-17T11:03:18Z","timestamp":1563361398000},"score":1,"resource":{"primary":{"URL":"http:\/\/cardiology.jamanetwork.com\/article.aspx?doi=10.1001\/jamacardio.2019.1176"}},"subtitle":["A Review"],"short-title":[],"issued":{"date-parts":[[2019,7,1]]},"references-count":37,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019,7,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamacardio.2019.1176","relation":{},"ISSN":["2380-6583"],"issn-type":[{"value":"2380-6583","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7,1]]}}}